CHRISTER ROSEN - 08 Nov 2024 Form 3 Insider Report for JUPITER NEUROSCIENCES, INC. (JUNS)

Role: Chairman and CEO, Director, 10%+ Owner
Signature: /s/ Christer Rosen
Issuer symbol: JUNS
Transactions as of: 08 Nov 2024
Net transactions value: $0
Form type: 3
Filing time: 08 Nov 2024, 21:53:39 UTC
Next filing: 01 Jul 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	JUNS	Common Stock						10,094,010	08 Nov 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	JUNS	Stock option (right to buy)							08 Nov 2024	Common Stock	811,812	$0.7400	Direct	F1
holding	JUNS	Stock option (right to buy)							08 Nov 2024	Common Stock	392,613	$0.8800	Direct	F2
holding	JUNS	Stock option (right to buy)							08 Nov 2024	Common Stock	710,344	$1.33	Direct	F3
holding	JUNS	Stock option (right to buy)							08 Nov 2024	Common Stock	88,909	$1.33	Direct	F4
holding	JUNS	Restricted stock award							08 Nov 2024	Common Stock	474,070	$0.000000	Direct	F5
holding	JUNS	Restricted stock unit							08 Nov 2024	Common Stock	497,397	$0.000000	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Fully vested stock options which were granted on January 24, 2019 under the Company's 2016 Equity Incentive Plan.
F2	Fully vested stock options which were granted on February 1, 2020 under the Company's 2016 Equity Incentive Plan.
F3	Fully vested stock options which were granted on September 29, 2023 pursuant to the approval of the board of directors of the issuer as partial consideration for forgiveness of earned compensation owed by the issuer to the Reporting Person.
F4	Fully vested stock options which were granted on December 18, 2023 pursuant to the approval of the board of directors of the issuer as partial consideration for forgiveness of earned compensation owed by the issuer to the Reporting Person.
F5	Restricted stock awards which were granted on July 22, 2022 under the Company's 2021 Equity Incentive Plan as partial consideration for forgiveness of earned compensation owed by the issuer to the Reporting Person. The restricted stock awards vest at 100% 180 days after the first day of trading of an IPO.
F6	Restricted stock units which were granted on December 18, 2023 under the Company's 2023 Equity Incentive Plan as partial consideration for forgiveness of earned compensation owed by the issuer to the Reporting Person. The restricted stock units vest at 100% 180 days after the first day of trading of an IPO.